Table 4. Content of Primary Care Office-Based and Telemedicine Visits, 2018-2020a.
| Variable | No., in thousands (%) | % Change (2020 Q2 vs 2018-2019 Q2)b | ||
|---|---|---|---|---|
| 2018-2019 (Q2) | 2020 (Q1) | 2020 (Q2) | ||
| Total visits, No. (95% CI) | 119 199 (114 038-124 360) | 110 705 (105 734-115 676) | 93 712 (89 270-98 154) | −21.4 |
| Blood pressure recorded | 88 675 (74.4) | 75 852 (68.5) | 44 229 (47.2) | −50.1 |
| Cholesterol assessed | 27 617 (23.2) | 22 803 (20.6) | 17 413 (18.5) | −36.9 |
| New medicines initiated | 54 142 (45.4) | 51 773 (46.8) | 40 079 (42.8) | −26.0 |
| Medicines continued | 38 024 (31.9) | 35 541 (32.1) | 34 621 (36.9) | −8.9 |
| New treatment visits | ||||
| Hypertension | 3414 (2.9) | 2714 (2.5) | 2078 (2.2) | −39.1 |
| Diabetes | 1408 (1.2) | 1226 (1.1) | 1177 (1.3) | −16.4 |
| High cholesterol | 1274 (1.1) | 1326 (1.2) | 926 (1.0) | −27.3 |
| Asthma | 1266 (1.1) | 1146 (1.0) | 635 (0.7) | −49.8 |
| Depression | 193 (0.2) | 157 (0.1) | 149 (0.2) | −22.8 |
| Insomnia | 396 (0.3) | 437 (0.4) | 299 (0.3) | −24.5 |
Abbreviation: Q, quarter.
a
Values represent average second quarter visit volume (2018-2019) and quarterly visit volume (2020 Q1 and 2020 Q2).
b
Percentage change depicts a comparison of the second quarter of 2020 (2020 Q2) with average volume of 2018 Q2 and 2019 Q2 combined.